Literature DB >> 1163358

Neonatal abstinence syndrome: assessment and management.

L P Finnegan, J F Connaughton, R E Kron, J P Emich.   

Abstract

A scoring system for the neonatal abstinence syndrome has been devised and implemented as both a clinical and investigative tool. The score monitors the passively addicted infant in a more comprehensive and objective fashion, and facilitates a more precise evaluation of the clinical status of the infant undergoing withdrawal. In addition, the scoring system has been applied in research designed to test the comparative usefulness of various pharmacologic agents currently recommended for the neonatal abstinence syndrome, and has been found useful in following the progression and diminution of withdrawal symptomatology before, during, and after therapy. Furthermore, the scoring system provides a basis ofr developing uniform criteria for the assessment and treatment of the neonate born to the addicted mother.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1163358

Source DB:  PubMed          Journal:  Addict Dis        ISSN： 0094-0267


  142 in total

Review 1.  Assessment and management of pain in neonates.

Authors:  B J Stevens; L S Franck
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns.

Authors:  C O'Brien; R Hunt; H E Jeffery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

3.  Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.

Authors:  Andjela Baewert; Reinhold Jagsch; Bernadette Winklbaur; Gerda Kaiser; Kenneth Thau; Annemarie Unger; Constantin Aschauer; Manfred Weninger; Verena Metz
Journal:  Eur Addict Res       Date:  2012-02-21       Impact factor: 3.015

4.  Neonatal seizures on EEG after in utero exposure to venlafaxine.

Authors:  Chris J C Hoppenbrouwers; Jacob Bosma; Hanneke J M B Wennink; Antonius A J Hilgevoord; Marion Heres; Adriaan Honig
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

5.  Integrative Review of Gut Microbiota and Expression of Symptoms Associated With Neonatal Abstinence Syndrome.

Authors:  Stephanie D Sealschott; Rita H Pickler; Christine A Fortney; Michael T Bailey
Journal:  Nurs Res       Date:  2020 Sep/Oct       Impact factor: 2.381

Review 6.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

7.  Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal.

Authors:  Tamorah Lewis; Betty Luan Erfe; Tarrah Ezell; Estelle Gauda
Journal:  J Opioid Manag       Date:  2015 Jul-Aug

Review 8.  Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.

Authors:  Eugene Ng; Anna Taddio; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

9.  An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome.

Authors:  Matthew R Grossman; Adam K Berkwitt; Rachel R Osborn; Yaqing Xu; Denise A Esserman; Eugene D Shapiro; Matthew J Bizzarro
Journal:  Pediatrics       Date:  2017-05-18       Impact factor: 7.124

10.  Cumulative environmental risk in substance abusing women: early intervention, parenting stress, child abuse potential and child development.

Authors:  Susan J Kelley
Journal:  Child Abuse Negl       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.